| Dr Kamlesh Pranshanker Pandya, MD | |
|
2100 Nebraska Ave Ste 202, Fort Pierce, FL 34950-4832 | |
| (772) 460-1510 | |
| (772) 460-1509 |
| Full Name | Dr Kamlesh Pranshanker Pandya |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 43 Years |
| Location | 2100 Nebraska Ave Ste 202, Fort Pierce, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750440020 | NPI | - | NPPES |
| 051911100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME0059031 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lawnwood Regional Medical Center & Heart Institute | Fort pierce, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lucie Medical Specialists Llc | 1456430487 | 38 |
News Archive
WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.
› Verified 9 days ago
| Entity Name | St Lucie Medical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548447535 PECOS PAC ID: 1456430487 Enrollment ID: O20080502000091 |
News Archive
WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.
› Verified 9 days ago
| Entity Name | Premier Inpatient Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568916492 PECOS PAC ID: 3476832528 Enrollment ID: O20161114002121 |
News Archive
WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.
› Verified 9 days ago
| Entity Name | Hni Hospital Services Of Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144851411 PECOS PAC ID: 0244661353 Enrollment ID: O20200505001799 |
News Archive
WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.
› Verified 9 days ago
| Entity Name | Premier Critical Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669064192 PECOS PAC ID: 6709275027 Enrollment ID: O20211108001528 |
News Archive
WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.
› Verified 9 days ago
| Entity Name | Intensivist Medicine Services Of Fl Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235836388 PECOS PAC ID: 3173998481 Enrollment ID: O20230418001601 |
News Archive
WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.
› Verified 9 days ago
| Entity Name | Hospital Medicine Services Of Fl, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710684857 PECOS PAC ID: 9234596743 Enrollment ID: O20230526001457 |
News Archive
WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kamlesh Pranshanker Pandya, MD 2100 Nebraska Ave Ste 202, Fort Pierce, FL 34950-4832 Ph: (772) 460-1510 | Dr Kamlesh Pranshanker Pandya, MD 2100 Nebraska Ave Ste 202, Fort Pierce, FL 34950-4832 Ph: (772) 460-1510 |
News Archive
WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.
A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.
Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, has presented 2 abstracts on Loramyc® and clonidine Lauriad® at the MASCC/ISOO 2010 International Symposium (Vancouver, June 24-26, 2010). These two products belong to the supportive care pipeline of BioAlliance Pharma.
› Verified 9 days ago
Sabrina Marie Seus, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 South 23rd Street, Lawnwood Regional Medical Center, Fort Pierce, FL 34950 Phone: 772-467-8291 | |
Ms. Kirsten Alexandra Nathan, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 S 23rd St, Fort Pierce, FL 34950 Phone: 772-461-4000 | |
Dr. Perry R Lloyd Iii, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2207 Sunrise Blvd, Fort Pierce, FL 34950 Phone: 772-465-0491 Fax: 772-461-6360 | |
Mrs. Marcy Ann Studzinski, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1900 Nebraska Avenue, Suite 9, Fort Pierce, FL 34950 Phone: 772-465-4499 Fax: 772-466-0832 | |
Mohammad Izhar, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 Hartman Rd Ste 1, Fort Pierce, FL 34947 Phone: 724-651-1707 Fax: 772-465-1171 | |
Mr. Kamalakar T Rao, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1900 Nebraska Avenue, Suite 9, Fort Pierce, FL 34950 Phone: 772-465-4499 Fax: 772-466-0832 | |
Dr. Samerah G Razuman, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 Hartman Rd Ste 1, Fort Pierce, FL 34947 Phone: 772-465-1170 Fax: 772-465-1171 |